Urovant Sciences Ltd.

CIK 1740547 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Urovant Sciences Ltd..

Recent SEC filings

FiledFormAccession number
Apr 8, 202115-12B0001193125-21-110220
Mar 31, 202140000899243-21-014102
Mar 31, 202140000899243-21-014107
Mar 31, 202140000899243-21-014101
Mar 31, 202140000899243-21-014106
Mar 31, 202140000899243-21-014103
Mar 31, 202140000899243-21-014109
Mar 31, 2021EFFECT9999999995-21-001220
Mar 31, 202140000899243-21-014104
Mar 31, 202140000899243-21-014108
Mar 31, 202140000899243-21-014110
Mar 31, 202140000899243-21-014105
Mar 30, 2021SC 13D/A0001193125-21-099584
Mar 29, 20218-K0001193125-21-097522
Mar 29, 202125-NSE0001354457-21-000422
Mar 29, 2021S-8 POS0001193125-21-098142
Mar 29, 2021S-8 POS0001193125-21-098134
Mar 29, 2021SC 13E3/A0001193125-21-098451
Mar 29, 2021S-8 POS0001193125-21-098151
Mar 29, 2021POS AM0001193125-21-098129
Mar 24, 20218-K0001193125-21-092665
Feb 19, 2021DEFM14A0001193125-21-048255
Feb 19, 2021SC 13E3/A0001193125-21-048264
Feb 16, 2021SC 13G/A0001193125-21-044731
Feb 12, 202110-Q0001564590-21-005814